Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2022

View Archived Issues

Novel hemophilia A murine model to test IdeS proteinase efficacy

Coagulant Therapeutics presents preclinical data on CT-001

Sunshine Lake Pharma patents new chymotrypsin inhibitors

Novartis divulges new cGAS inhibitors

Janssen Pharmaceutica presents new Mcl-1 inhibitors

Pfizer describes new IL-2 production inhibitors

Merck & Co. synthesizes orexin OX2 receptor agonists

PCYOX1 identified as new target for antithrombotic therapy

Enterome and Nestle Health Science collaborate to tackle food allergies and IBD

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

Defective gamma fibrinogen crosslinking exacerbates liver injury

Spread of Y chromosome deficiency in myeloid cells with age promotes cardiac fibrosis

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...